CO HB1010

Defines "provider-administered drug" as an outpatient drug (other than vaccines) that cannot reasonably be self-administered and is typically administered by a healthcare provider in their office.

Prohibits health insurance carriers from requiring provider-administered drugs to be dispensed only by specific network pharmacies for cancer or life-threatening disease treatment, effective for plans issued on or after January 1, 2025.

Prevents carriers from limiting coverage based on a patient's choice of participating provider and prohibits additional fees or copayments for using a different provider or pharmacy.

Requires written informed consent and provider attestation before billing for drug delivery and administration under the pharmacy benefit instead of the medical benefit.

Appropriates $7,333 to the Division of Insurance for the 2024-25 fiscal year to implement the law, assuming 0.1 additional FTE.